Where to Get GLP-1 for Weight Loss: Compounded & Branded Options

Last reviewed: May 30, 2026

Last updated: May 30, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

GLP-1 medications for weight loss are obtainable through branded pharmaceuticals (Ozempic, Wegovy, Mounjaro, Zepbound), telehealth platforms, compounding pharmacies, and traditional medical practices. Clinical evidence supports GLP-1 receptor agonists for weight management, with trials showing 15–22% body weight reduction over 68 weeks depending on formulation and individual factors.

Finding the right GLP-1 source requires balancing cost, pharmacy oversight, provider qualifications, and whether your genetic profile suggests stronger or weaker response patterns in key peptide pathways. PlexusDx focuses on precision access through licensed 503A compounding partners and optional genetic context to support more personalized conversations with your healthcare provider.

Branded Pharmaceuticals: Availability, Cost, and Regulatory Status

Branded GLP-1 products include semaglutide (Ozempic for diabetes, Wegovy for weight loss), tirzepatide (Mounjaro for diabetes, Zepbound for weight loss), and liraglutide (Saxenda for weight loss). These are FDA-approved, widely prescribed through traditional healthcare systems, and covered by some insurance plans, though out-of-pocket costs often exceed $900–$1,300 monthly without coverage.

Access to branded GLP-1s typically requires a prescription from a licensed physician and fulfillment through traditional or specialty pharmacies. Wait times and supply shortages have been common since 2023, and insurance formulary restrictions may limit availability depending on your plan and clinical indication.

Compounded GLP-1 Options: Quality, Sourcing, and Regulatory Oversight

Compounded GLP-1 medications (compounded semaglutide and tirzepatide) are prepared by licensed 503A compounding pharmacies under state pharmacy board oversight and FDA guidance. These are not branded pharmaceuticals but custom-prepared formulations, typically more affordable ($179–$309 monthly) and available with shorter lead times than branded equivalents.

Sourcing Type	Regulatory Framework	Typical Cost Range	Provider Requirement	Lead Time
Branded GLP-1s (Wegovy, Ozempic, Mounjaro)	FDA-approved; insurance-dependent coverage	$900–$1,300/month or insurance copay	Licensed MD/DO/NP/PA via traditional or telehealth	1–4 weeks due to demand
Compounded GLP-1s (503A)	State pharmacy board oversight; FDA guidance compliance	$179–$309/month	Licensed provider; telehealth partners available	3–7 days typical
Telehealth-only branded GLP-1	FDA-approved drugs; variable provider vetting	$500–$1,200/month	Telehealth-only physician	1–2 weeks
Unregulated compounding or overseas sourcing	Minimal to no oversight; high contamination risk	$50–$200/month	Often none or unlicensed	Variable; safety unknown

Genetic Predispositions in GLP-1 Pathways: Why Individual Response Varies

Research indicates that variants in GLP-1 receptor genes (GLP1R rs6923761), GIPR signaling (GIPR rs1800437), appetite regulation (FTO rs9939609), and melanocortin pathways (MC4R rs17782313) may contribute to individual differences in response to GLP-1 therapy. These predispositions do not predict exact medication success but may help provide context for why some patients achieve robust weight loss while others require dosage adjustments or combination approaches.

The Precision Peptide Genetic Test screens for variants in these key peptide pathway genes. This information should be interpreted with a qualified healthcare provider and may support a more personalized conversation about baseline expectations, dosing strategy, and whether combination therapies (such as GLP-Squared dual compounds) align with your genetic profile.

How to Evaluate GLP-1 Sources: A Clinical and Safety Framework

When selecting where to obtain GLP-1, prioritize: (1) licensed pharmacy oversight (503A compounding or traditional retail), (2) qualified prescribing provider with weight management or metabolic experience, (3) transparent pricing and no hidden fees, (4) baseline health screening (kidney function, thyroid status, cardiovascular history), and (5) ongoing clinical monitoring with dose adjustments based on response and tolerability.

Avoid sources without clear regulatory oversight, pressure to purchase without medical evaluation, or guarantees of weight loss outcomes. Ask whether your provider will monitor for adverse effects (nausea, pancreatitis risk, dehydration) and adjust your plan if needed. Genetic testing through a clinical partner like PlexusDx may add value if you want biomarker context, but it should complement, not replace, a thorough clinical assessment.

PlexusDx Compounded Options: Transparent Sourcing and Genetic Insights

PlexusDx partners exclusively with licensed 503A compounding pharmacies to provide compounded semaglutide ($179–$229/month), oral semaglutide ($209+/month), compounded tirzepatide ($229–$309/month), oral tirzepatide ($229–$509/month), and specialized formulations like Microdose GLP-1 Protocol ($129/month) and GLP-Squared dual compounds ($179–$325/month). All products are sourced through licensed, regulated pharmacies with transparent quality standards.

PlexusDx also offers the Precision Peptide Genetic Test ($99 add-on or $298 standalone) to reveal predispositions in GLP-1 and appetite-regulation pathways. This test is designed to support provider conversations about baseline response likelihood, not to predict exact medication outcomes. Combined with qualified provider oversight, this approach emphasizes precision, transparency, and informed decision-making over direct-to-consumer convenience alone.

How PlexusDx Supports a More Personalized Approach

PlexusDx's Precision Peptide Genetic Test analyzes variants in GLP1R, GIPR, FTO, and MC4R genes to reveal predispositions in peptide signaling pathways. These insights may help provide context for baseline response expectations and can support conversations with your provider about dosing strategy and whether combination formulations might be beneficial.

It is essential to understand that genetic predispositions do not guarantee specific medication outcomes or side effect profiles. The test identifies inherited variations associated with peptide pathway sensitivity, not exact GLP-1 efficacy. Results should always be interpreted with a qualified healthcare provider in the context of your full medical history, current medications, and weight management goals.

By combining PlexusDx's compounded formulations (sourced through licensed 503A pharmacies) with optional genetic pathway insights and structured provider partnership, you gain transparency about sourcing quality, cost structure, and biological context. This integrated approach can support a more informed and personalized conversation with your healthcare team about the best GLP-1 strategy for your unique circumstances.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month, or $298 standalone) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Tirzepatide Injection starts at $229-$309/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.